Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas

ClinicalTrials.gov ID: NCT04620187

Public ClinicalTrials.gov record NCT04620187. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 6, 2026, 8:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study of Adjuvant Ado-trastuzumab Emtansine (T-DM1) in HER2-positive Salivary Gland Carcinomas

Study identification

NCT ID: NCT04620187
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Dana-Farber Cancer Institute; Other
Enrollment: 37 participants

Conditions and interventions

Conditions

Interventions

Ado-trastuzumab (T) emtansine (T-DM1) Drug
Standard of Care Chemotherapy Drug
Standard of Care Radiotherapy Radiation

Drug · Radiation

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 23, 2020
Primary completion: Jan 31, 2028
Completion: Jan 31, 2029
Last update posted: Apr 12, 2026

2020 – 2029

United States locations

U.S. sites: 13
U.S. states: 6
U.S. cities: 11

Facility	City	State	ZIP	Site status
Winship Cancer Institute, Emory University	Atlanta	Georgia	30322	Recruiting
University of Chicago	Chicago	Illinois	60637	Recruiting
Brigham and Women's Hospital	Boston	Massachusetts	02115	Recruiting
Dana Farber Cancer Institute	Boston	Massachusetts	02115	Recruiting
Memorial Sloan Kettering Basking Ridge	Basking Ridge	New Jersey	07920	Recruiting
Memorial Sloan Kettering Monmouth	Middletown	New Jersey	07748	Recruiting
Memorial Sloan Kettering Bergen	Montvale	New Jersey	07645	Recruiting
Memorial Sloan Kettering Commack	Commack	New York	11725	Recruiting
Memorial Sloan Kettering Westchester	Harrison	New York	10604	Recruiting
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center	New York	New York	10021	Recruiting
Memorial Sloan Kettering Cancer Center	New York	New York	10065	Recruiting
Memorial Sloan Kettering Nassau	Uniondale	New York	11553	Recruiting
University of Washington Medical Center	Seattle	Washington	98195	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT04620187, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 12, 2026 · Synced May 6, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04620187 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →